SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 60.53 |
| Enterprise Value ($M) | 59.08 |
| Book Value ($M) | 3.20 |
| Book Value / Share | 0.01 |
| Price / Book | 18.91 |
| NCAV ($M) | 0.43 |
| NCAV / Share | 0.00 |
| Price / NCAV | 139.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.67 |
| Return on Assets (ROA) | 0.72 |
| Return on Equity (ROE) | 1.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.09 |
| Current Ratio | 1.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.28 |
| Assets | 5.05 |
| Liabilities | 1.85 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| ENZN – Enzon Pharmaceuticals, Inc. | ERGO – Entia Biosciences, Inc. |
| ETNI – Entest Group, Inc. | EVFM – Evofem Biosciences, Inc. |
| EVLO – Evelo Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io